Executive Medical Director – Global Clinical Lead, Hematology/Oncology

Kaye/Bassman International; Boston (MA); On-site; USD 350,000 - 550,000; Full time

Job summary

Kaye/Bassman International is leading a high-visibility search for an Executive Medical Director / Global Clinical Lead to drive a late-stage Phase 3 hematology program in myeloid malignancies (AML/MDS/MPN) for a global biopharma. The role requires a hematologist-oncologist with Phase 3 leadership to own clinical strategy end-to-end, including FDA interactions and Advisory Committee exposure.

You will lead a global development team across the US, EU, and Asia, make go/no-go and labeling

Qualifications

• MD or MD/PhD (U.S. clinical training preferred, not required).
• 10+ years in pharmaceutical/biotech clinical research, including Phase 1–4 development.
• Phase 3 leadership experience in hematology/oncology (AML/MDS/MPN) preferred.

Responsibilities

• Clinical strategy for a Phase 3 program in myeloid malignancies, from pivotal execution through registration.
• Lead a global development team across the US, EU, and Asia.
• Make go/no-go and labeling-critical decisions.
• Interact with FDA and other health authorities, including Advisory Committee preparation.

Skills

Executive leadership

Global development leadership

Regulatory interactions

Cross-functional collaboration

Education

MD or MD/PhD

Job description

Kaye/Bassman is leading a high-visibility search for an Executive Medical Director / Global Clinical Lead to drive a late-stage Phase 3 hematology program in myeloid malignancies (AML/MDS/MPN) for a global biopharma

This is a rare opportunity for a hematologist-oncologist or medical oncologist with Phase 3 leadership experience to own clinical strategy end-to-end: from pivotal execution through registration (NDA/MAA/BLA) and into launch planning, with direct FDA interaction and Advisory Committee exposure.

What you’ll own

• Clinical strategy for a Phase 3 program in myeloid malignancies, from pivotal execution through registration and toward launch
• Leadership of the global development team across the US, EU, and Asia
• Go/no-go and labeling-critical decisions
• Clinical science interactions with FDA and other health authorities, including Advisory Committee preparation
• Close partnership with Medical Affairs and senior Commercial leadership
• Direct reporting line to the Head of Clinical Development, with scope to expand into additional indications or earlier-stage programs

What you bring

• MD or MD/PhD (U.S. clinical training preferred, not required)
• 10+ years in pharmaceutical/biotech clinical research, including Phase 1–4 clinical development
• Phase 3 leadership experience in hematology or oncology — hematologic malignancies (AML, MDS, MPN, lymphoma, myeloma) strongly preferred
• Experience with NDA/MAA/BLA submissions and regulatory health authority interactions
• Experience leading global, matrixed development teams
• Large pharma experience preferred; candidates with a mix of large pharma and biotech backgrounds are encouraged to apply
• Strong executive presence with the ability to influence senior clinical and commercial leadership